Clinical InvestigationT-Lymphocyte-Based Renin Angiotensin (cas 1407-47-2) System in Obesity

Add time:10/01/2019    Source:sciencedirect.com

ABSTRACTBackgroundObesity can be associated with increased cardio-metabolic risk, but some subjects with obesity do not show metabolic impairment and escape this association. Low-grade inflammation (i.e., high sensitivity C-reactive protein [hsCRP] > 3 mg/dL) is associated with high cardiovascular risk in obesity. We investigated renin-Angiotensin (cas 1407-47-2) system (RAS) activity in cultured circulating T-cells in subjects with obesity with and without angiotensin II (Ang II) stimulation in the presence or absence of low-grade inflammation.

We also recommend Trading Suppliers and Manufacturers of Angiotensin (cas 1407-47-2). Pls Click Website Link as below: cas 1407-47-2 suppliers

Prev:Mast cell peptidases (carboxypeptidase A and chymase)-mediated hydrolysis of human Angiotensin (cas 1407-47-2)-(1–12) substrate
Next:Angiotensin (cas 1407-47-2) II type 2 receptor and Angiotensin (cas 1407-47-2)-converting enzyme 2 mediate ischemic renal injury in diabetic and non-diabetic rats)